SYS6023

DRUG2 trials

Sponsors

CSPC Megalith Biopharmaceutical Co.,Ltd.

Conditions

Advanced Breast CancerAdvanced Solid Tumor

Phase 1

A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors

RecruitingNCT07110883

CSPC Megalith Biopharmaceutical Co.,Ltd.Advanced Solid Tumor

Start: 2024-08-15End: 2028-10-31Target: 400Updated: 2025-08-08

Phase 2

A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer

Not yet recruitingNCT07597629

CSPC Megalith Biopharmaceutical Co.,Ltd.Advanced Breast Cancer

Start: 2026-05-30End: 2029-05-30Target: 114Updated: 2026-05-19